Literature DB >> 24976777

HOXA11 and MMP2 gene expression in uterosacral ligaments of women with pelvic organ prolapse.

Nafiye Yılmaz1, Gülnur Ozaksit1, Yunus Kasım Terzi2, Saynur Yılmaz1, Burcu Budak1, Orhan Aksakal1, Feride İffet Sahin2.   

Abstract

OBJECTIVE: Pelvic organ prolapse (POP) is a common disorder that negatively impacts the quality of life in many women. Uterosacral ligaments (USLs) are supportive structures of the pelvic organs that are often attenuated in women with POP. The HOXA genes regulate the development of the uterosacral ligaments. We compared expression of HOXA11 and MMP2 in USLs of women with and without POP.
MATERIAL AND METHODS: A prospective sequential cross sectional study was conducted in ZTB Women's Health Research and Education Hospital. We compared expression of HOXA11 and MMP2 in USLs of women with (n:18) and without (n: 15) POP. Total RNA was isolated from patient (n:18) and control (n:15) uterosacral ligament tissues with TriPure isolation reagent according to the manufacturer's instructions. Expression levels of HOXA11 and MMP2 were determined using semiquantitative RT-PCR in a Light Cycler 480 system. Real-time ready catalog assays, which are short FAM-labeled hydrolysis probes containing locked nucleic acid, were used for RT-PCR reactions.
RESULTS: There was no difference in patients' mean age, parity, body mass indexes, and menopausal status between two groups. Means of RNA expression of MMP2 were 1.27±0.6 and 0.75±0.4 in the POP group vs control group, respectively (p:0.007). Means of RNA expression of HOXA 11 were 2.57±2.4 and 1.94±1.4 in the POP group vs control group, respectively (p:0.376). The POP group was divided as mild and severe POP; there was no difference in HOXA11 and MMP2 RNA expression between groups (p>0.05).
CONCLUSION: Although there was no difference HOXA11 RNA expression in USLs with the POP group vs control, there was a significant difference MMP2 RNA expression in USLs with the POP group vs control. There are limited studies on this subject, and study results are contradictory. Further investigations with larger numbers of cases are needed to clarify this subject.

Entities:  

Keywords:  HOXA11; MMP2; pelvic organ prolapse

Year:  2014        PMID: 24976777      PMCID: PMC4072547          DOI: 10.5152/jtgga.2014.0088

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  38 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Pelvic organ prolapse in nulliparous women and their parous sisters.

Authors:  Gunhilde M Buchsbaum; Erin E Duecy; Lindsey A Kerr; Li-Shan Huang; MaryAnn Perevich; David S Guzick
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

3.  Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.

Authors:  Margaret M Roebuck; Timothy R Helliwell; Iskander H Chaudhry; Socrates Kalogrianitis; Stuart Carter; Graham J Kemp; David A Ritchie; Michael J Jane; Simon P Frostick
Journal:  Am J Clin Pathol       Date:  2005-03       Impact factor: 2.493

4.  Rectus fascia colpopexy for post-hysterectomy vault prolapse: a valid option.

Authors:  Rajiv Mahendru
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-06-01

5.  Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness.

Authors:  H W Chung; Y Wen; S H Chun; C Nezhat; B H Woo; M Lake Polan
Journal:  Fertil Steril       Date:  2001-01       Impact factor: 7.329

6.  Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium.

Authors:  H S Taylor; P Igarashi; D L Olive; A Arici
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

Review 7.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

8.  Knockdown of Hoxa11 in vivo in the uterosacral ligament and uterus of mice results in altered collagen and matrix metalloproteinase activity.

Authors:  Yan Ma; Marsha Guess; Akshita Datar; Alex Hennessey; Ingrid Cardenas; Joshua Johnson; Kathleen A Connell
Journal:  Biol Reprod       Date:  2012-04-05       Impact factor: 4.285

9.  Pelvic organ prolapse and connective tissue abnormalities in Korean women.

Authors:  Sang Wook Bai; Byung Hoon Choe; Jeong Yeon Kim; Ki Hyun Park
Journal:  J Reprod Med       Date:  2002-03       Impact factor: 0.142

Review 10.  Familial transmission of urogenital prolapse and incontinence.

Authors:  Christian Twiss; Veronica Triaca; Larissa V Rodríguez
Journal:  Curr Opin Obstet Gynecol       Date:  2007-10       Impact factor: 1.927

View more
  5 in total

Review 1.  Mechanics of Uterosacral Ligaments: Current Knowledge, Existing Gaps, and Future Directions.

Authors:  Kandace Donaldson; Alyssa Huntington; Raffaella De Vita
Journal:  Ann Biomed Eng       Date:  2021-03-22       Impact factor: 3.934

2.  Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.

Authors:  Liming Cui; Bo Gao; Zhigang Cao; Xiaoying Chen; Shide Zhang; Weizhe Zhang
Journal:  Mol Med Rep       Date:  2016-01-12       Impact factor: 2.952

3.  Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse.

Authors:  Lifang Zhang; Ping Zheng; Aihong Duan; Yan Hao; Chang Lu; Dan Lu
Journal:  Mol Med Rep       Date:  2018-11-13       Impact factor: 2.952

4.  The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration.

Authors:  Yating Cheng; Indira Jutooru; Gayathri Chadalapaka; J Christopher Corton; Stephen Safe
Journal:  Oncotarget       Date:  2015-05-10

5.  Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Authors:  Young-Bem Se; Seung Hyun Kim; Ji Young Kim; Ja Eun Kim; Yun-Sik Dho; Jin Wook Kim; Yong Hwy Kim; Hyun Goo Woo; Se-Hyuk Kim; Shin-Hyuk Kang; Hak Jae Kim; Tae Min Kim; Soon-Tae Lee; Seung Hong Choi; Sung-Hye Park; Il Han Kim; Dong Gyu Kim; Chul-Kee Park
Journal:  Cancer Res Treat       Date:  2016-07-19       Impact factor: 4.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.